Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01RHR
|
||||
| Former ID |
DIB019445
|
||||
| Drug Name |
compound 31
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532836] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C29H23F3N6O3
|
||||
| InChI |
InChI=1S/C29H23F3N6O3/c1-3-25(39)35-20-8-5-9-21(13-20)38-28-33-15-23(16-34-28)37-27(41)24-14-22(11-10-17(24)2)36-26(40)18-6-4-7-19(12-18)29(30,31)32/h3-16H,1H2,2H3,(H,35,39)(H,36,40)(H,37,41)(H,33,34,38)
|
||||
| InChIKey |
BTWVWABAWDKQNJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | tec protein tyrosine kinase | Target Info | Inhibitor | [532836] | |
| BLK proto-oncogene, Src family tyrosine kinase | Target Info | Inhibitor | [532836] | ||
| Tyrosine-protein kinase BTK | Target Info | Inhibitor | [532836] | ||
| BMX non-receptor tyrosine kinase | Target Info | Inhibitor | [532836] | ||
| TXK tyrosine kinase | Target Info | Inhibitor | [532836] | ||
| PANTHER Pathway | B cell activation | ||||
| PathWhiz Pathway | Fc Epsilon Receptor I Signaling in Mast Cells | ||||
| Reactome | MyD88:Mal cascade initiated on plasma membrane | ||||
| Regulation of actin dynamics for phagocytic cup formation | |||||
| DAP12 signaling | |||||
| FCERI mediated Ca+2 mobilization | |||||
| MyD88 deficiency (TLR2/4) | |||||
| IRAK4 deficiency (TLR2/4) | |||||
| RHO GTPases Activate WASPs and WAVEs | |||||
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.